| Ministry of Health, AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting]. | 암
> 암: 대부분의 유형 | 규제 파트너십
> 규제 기관과의 협력 | 100,000 | National | Regularly | 114997934765 |
| Collaboration with AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System], RPP [Rzecznik Praw Pacjenta – Patient Rights Ombudsman], and MZ [Ministerstwo Zdrowia – Ministry of Health]. | 류마티스성
> 류마티스 질환: 대부분의 유형 | 규제 파트너십
> 규제 기관과의 협력 | Do not know | National | Sometimes | 115034231072 |
| The Ministry of Health, the Parliamentary Bureau for Rare Diseases, and the Agency for Health Technology Assessment [in Poland]. | 신경퇴행성
> 헌팅턴병 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 10,000 | National | Regularly | 114998054778 |
| Patients have one reimbursed therapy; she has therefore participated in AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting] consultations on that single occasion. | 신경학적
> 신경섬유종증(NF) | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 10,000 | National | Rarely | 115001091579 |
| Opinions solicited by AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System]. | 혈액
> 혈액 질환: 대부분의 유형 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 10,000 | National | Sometimes | 115012243141 |
| Participation in subcommittees of the Sejm [lower house of the bicameral parliament of Poland] and at AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting]. | 신경근
> 신경근육 질환: 대부분의 유형 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 100 | National | Regularly | 115016498985 |
| AOTM [Agencja Oceny Technologii Medycznych – Agency for Health Technology Assessment], MZ [Ministerstwo Zdrowia – Ministry of Health], and NFZ [Narodowy Fundusz Zdrowia – National Health Fund] — meetings. | 신경학적
> 다발성 경화증 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 10,000 | National | Regularly | 115020534401 |
| Participation in meetings of the AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System] Transparency Council, as well as meetings at the Ministry of Health, including with the Department of Medicines Policy and Pharmacy. | 만성
> 자조 모임 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 5,000 | National | Regularly | 115028436607 |
| AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System]; drug programmes. | 신장
> 신장 질환 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 10,000 | National | Regularly | 115028692487 |
| ... Direct meetings with representatives of the Ministry of Health [in Poland] and NFZ [Narodowy Fundusz Zdrowia – National Health Fund]; participation in conferences and debates involving the MZ [Ministerstwo Zdrowia – Ministry of Health], NFZ, and AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System]. | 일반 건강
> 비만 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 100,000 | National | Regularly | 115034209832 |
| Collaboration with AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System], RPP [Rzecznik Praw Pacjenta – Patient Rights Ombudsman], and MZ [Ministerstwo Zdrowia – Ministry of Health]. | 류마티스성
> 류마티스 질환: 대부분의 유형 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | Do not know | National | Sometimes | 115034231072 |
| AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting] consultations concerning an innovative therapy for paediatric patients with NF [Neurofibromatosis]. | 신경학적
> 신경섬유종증(NF) | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 1,000 | National | Rarely | 115040684008 |
| Participation in meetings of the Transparency Council of AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System]. | 호흡기
> 폐 섬유증 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 100 | National | Rarely | 115044635845 |
| Meetings at the MZ [Ministerstwo Zdrowia – Ministry of Health]. | 출혈
> 출혈 장애: 대부분의 유형 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | 100 | National | Regularly | 115017164453 |
| AOTM [Agencja Oceny Technologii Medycznych – Agency for Health Technology Assessment], MZ [Ministerstwo Zdrowia – Ministry of Health], and NFZ [Narodowy Fundusz Zdrowia – National Health Fund] — meetings. | 신경학적
> 다발성 경화증 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | 10,000 | National | Regularly | 115020534401 |
| Participation in meetings of the AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System] Transparency Council, as well as meetings at the Ministry of Health, including with the Department of Medicines Policy and Pharmacy. | 만성
> 자조 모임 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | 5,000 | National | Regularly | 115028436607 |
| ... Direct meetings with representatives of the Ministry of Health [in Poland] and NFZ [Narodowy Fundusz Zdrowia – National Health Fund]; participation in conferences and debates involving the MZ [Ministerstwo Zdrowia – Ministry of Health], NFZ, and AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System]. | 일반 건강
> 비만 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | 100,000 | National | Regularly | 115034209832 |
| Participation in meetings of the Transparency Council of AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff System]. | 호흡기
> 폐 섬유증 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | 100 | National | Rarely | 115044635845 |
| … convening meetings in the Sejm [lower house of the bicameral parliament of Poland] and the Senate. | 희귀
> 희귀 질환: 대부분의 유형 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | 100,000 | National | Regularly | 115051819029 |
| Our activities include organising discussion panels with representatives of regulatory authorities. | 희귀
> 희귀 질환: 대부분의 유형 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | 100,000 | National | Regularly | 115051819029 |
| The Sejm [lower house of the bicameral parliament of Poland] and the Senate. | 암
> 암: 혈액 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | 100 | National | Rarely | 115055421449 |
| Petitions, meetings, position statements, and ministerial engagements. | 혈액
> 혈액 질환: 대부분의 유형 | 정책 및 법률에 영향 미치기
> 의료 정책 및 법률에 영향력 행사 | 100 | Not specified | Regularly | 115004706817 |
| Organising discussion panels with the participation of regulatory authority representatives; holding meetings in the Sejm (lower house of parliament) and the Senate; engaging with parliamentary working groups, committees, and councils operating under the Minister of Health and the Patient Rights Ombudsman. | 희귀
> 희귀 질환: 대부분의 유형 | 정책 및 법률에 영향 미치기
> 의료 정책 및 법률에 영향력 행사 | 100,000 | National | Regularly | 115051819029 |
| Petitions, meetings, position statements, and ministerial engagements. | 혈액
> 혈액 질환: 대부분의 유형 | 정책 및 법률에 영향 미치기
> 공청회 및 협의에 참여하기 | 100 | Not specified | Regularly | 115004706817 |
| Consultations concerning the Governmental Legislative Process and, for example, draft directives issued by the President of the NFZ [Narodowy Fundusz Zdrowia – National Health Fund] regarding the terms and conditions for entering into and implementing contracts in the area of hospital treatment within the scope of chemotherapy. | 암
> 암: 혈액 | 정책 및 법률에 영향 미치기
> 공청회 및 협의에 참여하기 | 1,000 | National | Sometimes | 115006821188 |
| Petitions, position statements, and public speaking engagements. | 암
> 암: 혈액 | 정책 및 법률에 영향 미치기
> 공청회 및 협의에 참여하기 | We do not communicate with patients directly | National | Regularly | 115008148315 |
| The Sejm [lower house of the bicameral parliament of Poland], parliamentary committees, and the Patient Rights Ombudsman. | 암
> 암: 혈액 | 정책 및 법률에 영향 미치기
> 공청회 및 협의에 참여하기 | 1,000 | National | Sometimes | 115009429955 |
| Parliamentary committee sessions, and presentations delivered within national panel discussions at conferences. | 신장
> 신장 질환 | 정책 및 법률에 영향 미치기
> 공청회 및 협의에 참여하기 | 100,000 | National | Regularly | 115055443581 |
| Petitions, meetings, position statements, and ministerial engagements. | 혈액
> 혈액 질환: 대부분의 유형 | 정책 및 법률에 영향 미치기
> 의회 의원 및 정치 지도자 동원 | 100 | Not specified | Regularly | 115004706817 |
| AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting] consultations concerning an innovative therapy for paediatric patients with NF [Neurofibromatosis]. | 신경학적
> 신경섬유종증(NF) | 정책 및 법률에 영향 미치기
> 의료 서비스의 장벽/이상 현상 해결 | 1,000 | National | Rarely | 115040684008 |
| Consultations concerning the Governmental Legislative Process and, for example, draft directives issued by the President of the NFZ [Narodowy Fundusz Zdrowia – National Health Fund] regarding the terms and conditions for entering into and implementing contracts in the area of hospital treatment within the scope of chemotherapy. | 암
> 암: 혈액 | 가격 책정 및 affordability 옹호
> 가격 검토 위원회 협상에 참여 | 1,000 | National | Sometimes | 115006821188 |
| Participation in subcommittees of the Sejm [lower house of the bicameral parliament of Poland] and at AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting]. | 신경근
> 신경근육 질환: 대부분의 유형 | 가격 책정 및 affordability 옹호
> 가격 검토 위원회 협상에 참여 | 100 | National | Regularly | 115016498985 |
| Patients have one reimbursed therapy; we therefore participated in AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting] consultations on that single occasion [in Poland]. | 신경학적
> 신경섬유종증(NF) | 가격 책정 및 affordability 옹호
> 제품의 급여 목록/국가 처방집 등재 옹호 | 10,000 | National | Rarely | 115001091579 |
| Consultations concerning the Governmental Legislative Process and, for example, draft directives issued by the President of the NFZ [Narodowy Fundusz Zdrowia – National Health Fund] regarding the terms and conditions for entering into and implementing contracts in the area of hospital treatment within the scope of chemotherapy. | 암
> 암: 혈액 | 가격 책정 및 affordability 옹호
> 제품의 급여 목록/국가 처방집 등재 옹호 | 1,000 | National | Sometimes | 115006821188 |
| Several years ago, we were consulted on an anti-epileptic medicine with regard to its inclusion on the list of medicines available free of charge. | 신경학적
> 간질 | 가격 책정 및 affordability 옹호
> 제품의 급여 목록/국가 처방집 등재 옹호 | 1,000 | National | Rarely | 115060454872 |
| We identify areas in which access to innovative therapies is restricted relative to international guidelines. | 암
> 암: 대부분의 유형 | 접근 경로 개선
> 의약품/의료서비스에 대한 공평한 접근 촉진 | 100,000 | National | Sometimes | 115016953105 |
| ... Submission of formal written communications addressing patient needs. | 일반 건강
> 비만 | 근거 기반 환자 의견
> 환자 인사이트를 활용하여 의사 결정에 반영하세요 | 100,000 | National | Regularly | 115034209832 |
| Several years ago, we were consulted on an anti-epileptic medicine with regard to its inclusion on the list of medicines available free of charge. | 신경학적
> 간질 | 근거 기반 환자 의견
> 환자 인사이트를 활용하여 의사 결정에 반영하세요 | 1,000 | National | Rarely | 115060454872 |
| The Sejm [lower house of the bicameral parliament of Poland], parliamentary committees, and the Patient Rights Ombudsman. | 암
> 암: 혈액 | 기관 거버넌스
> 정부 자문 기구 내 대표성 확보 | 1,000 | National | Sometimes | 115009429955 |
| Participation in subcommittees of the Sejm [lower house of the bicameral parliament of Poland] and at AOTMiT [Agencja Oceny Technologii Medycznych i Taryfikacji – Agency for Health Technology Assessment and Tariff Setting]. | 신경근
> 신경근육 질환: 대부분의 유형 | 기관 거버넌스
> 정부 자문 기구 내 대표성 확보 | 100 | National | Regularly | 115016498985 |
| Permanent membership of the Expert Team on Obesity Prevention, attached to the Public Health Council [in Poland]. | 일반 건강
> 비만 | 기관 거버넌스
> 정부 자문 기구 내 대표성 확보 | 100,000 | National | Regularly | 115034209832 |
| The Sejm [lower house of the bicameral parliament of Poland], the Senate, MZ [Ministerstwo Zdrowia – Ministry of Health], NFZ [Narodowy Fundusz Zdrowia – National Health Fund], RPP [Rada Przejrzystości – Transparency Council]. | 암
> 암: 대부분의 유형 | 기관 거버넌스
> 정부 자문 기구 내 대표성 확보 | 10,000 | National | Regularly | 115035934051 |
| Organising discussion panels with the participation of regulatory authority representatives; holding meetings in the Sejm (lower house of parliament) and the Senate; engaging with parliamentary working groups, committees, and councils operating under the Minister of Health and the Patient Rights Ombudsman. | 희귀
> 희귀 질환: 대부분의 유형 | 기관 거버넌스
> 정부 자문 기구 내 대표성 확보 | 100,000 | National | Regularly | 115051819029 |
| The Sejm [lower house of the bicameral parliament of Poland], the Senate, MZ [Ministerstwo Zdrowia – Ministry of Health], NFZ [Narodowy Fundusz Zdrowia – National Health Fund], RPP [Rada Przejrzystości – Transparency Council]. | 암
> 암: 대부분의 유형 | 기관 거버넌스
> 다중 이해관계자 네트워크 내에서 효과적으로 협력하기 | 10,000 | National | Regularly | 115035934051 |
상호작용
활동 및 옹호
20 멘션
